ZMIZ1 preferably enhances the transcriptional activity of androgen receptor with short polyglutamine tract

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Li, Xiaomeng ^a,b   Zhu, Chunfang ^a   Tu, William H ^a   Yang, Nanyang ^b   Qin, Hui ^b   Sun, Zijie ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; BAF57 PROTEIN; BARRIER TO AUTOINTEGRATION FACTOR; BRG1 PROTEIN; POLYGLUTAMINE; PROTEIN INHIBITOR OF ACTIVATED STAT; UNCLASSIFIED DRUG; ZMIZ1 PROTEIN; ZMIZ2 PROTEIN; AR PROTEIN, HUMAN; PEPTIDE; PROSTATE SPECIFIC ANTIGEN; TRANSCRIPTION FACTOR; ZMIZ1 PROTEIN, HUMAN; ZMIZ2 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE; HUMAN; HUMAN CELL; PROMOTER REGION; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN GENE; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; GENETICS; IMMUNOPRECIPITATION; MALE; METABOLISM; PROSTATE TUMOR; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; HUMANS; IMMUNOPRECIPITATION; MALE; PEPTIDES; PROMOTER REGIONS, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN INHIBITORS OF ACTIVATED STAT; RECEPTORS, ANDROGEN; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 80052946890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025040     Document Type: Article

References (48)

1. Jenster G, (1999) The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26: 407-421.
2. Zhou ZX, Wong CI, Sar M, Wilson EM, (1994) The androgen receptor: an overview. Recent Progress Hormone Research 49: 249-274.
3. Choong CS, Wilson EM, (1998) Trinucleotide repeats in the human androgen receptor: a molecular basis for disease. J Mol Endocrinol 21: 235-257.
4. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, et al. (1993) Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet 5: 184-188.
5. Palazzolo I, Gliozzi A, Rusmini P, Sau D, Crippa V, et al. (2008) The role of the polyglutamine tract in androgen receptor. J Steroid Biochem Mol Biol 108: 245-253.
6. Ferlin A, Garolla A, Bettella A, Bartoloni L, Vinanzi C, et al. (2005) Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. Eur J Endocrinol 152: 419-425.
7. Ferlin A, Bartoloni L, Rizzo G, Roverato A, Garolla A, et al. (2004) Androgen receptor gene CAG and GGC repeat lengths in idiopathic male infertility. Mol Hum Reprod 10: 417-421.
8. Brinkmann A, Jenster G, Ris-Stalpers C, van der Korput H, Bruggenwirth H, et al. (1996) Molecular basis of androgen insensitivity. Steroids 61: 172-175.
9. Kazemi-Esfarjani P, Trifiro MA, Pinsky L, (1995) Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4: 523-527.
10. Salinas CA, Austin MA, Ostrander EO, Stanford JL, (2005) Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk. Prostate 65: 58-65.
11. Stanford JL, Just JJ, Gibbs M, Wicklund KG, Neal CL, et al. (1997) Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res 57: 1194-1198.
12. Clark PE, Irvine RA, Coetzee GA, (2003) The androgen receptor CAG repeat and prostate cancer risk. Methods Mol Med 81: 255-266.
13. Heinlein CA, Chang C, (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16: 2181-2187.
14. Balk SP, (2002) Androgen receptor as a target in androgen-independent prostate cancer. Urology 60: 132-138; discussion 138-139.
15. Sanchez ER, Faber LE, Henzel WJ, Pratt WB, (1990) The 56-59-kilodalton protein identified in untransformed steroid receptor complexes is a unique protein that exists in cytosol in a complex with both the 70- and 90-kilodalton heat shock proteins. Biochemistry 29: 5145-5152.
16. Buchanan G, Irvine RA, Coetzee GA, Tilley WD, (2001) Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev 20: 207-223.
17. Irvine RA, Ma H, Yu MC, Ross RK, Stallcup MR, et al. (2000) Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length. Hum Mol Genet 9: 267-274.
18. Ferro P, Catalano MG, Dell'Eva R, Fortunati N, Pfeffer U, (2002) The androgen receptor CAG repeat: a modifier of carcinogenesis? Mol Cell Endocrinol 193: 109-120.
19. Wang Q, Udayakumar TS, Vasaitis TS, Brodie AM, Fondell JD, (2004) Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells. J Biol Chem 279: 17319-17328.
20. Hsiao PW, Lin DL, Nakao R, Chang C, (1999) The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J Biol Chem 274: 20229-20234.
21. Sharma M, Li X, Wang Y, Zarnegar M, Huang CY, et al. (2003) hZimp10 is an androgen receptor co-activator and forms a complex with SUMO-1 at replication foci. Embo J 22: 6101-6114.
22. Jackson PK, (2001) A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases. Genes Dev 15: 3053-3058.
23. Beliakoff J, Sun Z, (2006) Zimp7 and Zimp10, two novel PIAS-like proteins, function as androgen receptor coregulators. Nucl Recept Signal 4: e017.
24. Sun Z, Pan J, Balk SP, (1997) Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 gene. Nucleic Acids Res 25: 3318-3325.
25. Yeh S, Chang C, (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. PNAS 93: 5517-5521.
26. Huang CY, Beliakoff J, Li X, Lee J, Li X, et al. (2005) hZimp7, a novel PIAS-like protein, enhances androgen receptor-mediated transcription and interacts with SWI/SNF-like BAF complexes. Mol Endocrinol 19: 2915-2929.
27. Cleutjens KB, van Eekelen CC, van der Korput HA, Brinkman AO, Trapman J, (1996) Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specfic antigen promoter. J Biol Chem 271: 6379-6388.
28. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, et al. (1995) Mutation of the androgen-receptor gene in metastatic androgen- independent prostate cancer. N Engl J Med 332: 1393-1398.
29. Hronovsky V, Plaisner V, Benda R, (1978) CV-1 monkey kidney cell line - a highly susceptible substrate for diagnosis and study of arboviruses. Acta Virol 22: 123-129.
30. Yamamichi-Nishina M, Ito T, Mizutani T, Yamamichi N, Watanabe H, et al. (2003) SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level. J Biol Chem 278: 7422-7430.
31. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
32. Farson D, Witt R, McGuinness R, Dull T, Kelly M, et al. (2001) A new-generation stable inducible packaging cell line for lentiviral vectors: A third-generation lentivirus vector with a conditional packaging system. Hum Gene Ther 12: 981-997.
33. Sharma M, Zarnegar M, Li X, Lim B, Sun Z, (2000) Androgen receptor interacts with a novel MYST protein, HBO1. J Biol Chem 275: 35200-35208.
34. Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, et al. (2003) Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proc Natl Acad Sci U S A 100: 2226-2230.
35. Shang Y, Myers M, Brown M, (2002) Formation of the androgen receptor transcription complex. Mol Cell 9: 601-610.
36. Irvine RA, Yu MC, Ross RK, Coetzee GA, (1995) The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res 55: 1937-1940.
37. Gutierrez L, Zurita M, Kennison JA, Vazquez M, (2003) The Drosophila trithorax group gene tonalli(tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein. Development 130: 343-354.
38. Gelmann EP, (2002) Molecular biology of the androgen receptor. J Clin Oncol 20: 3001-3015.
39. Grossmann ME, Huang H, Tindall DJ, (2001) Androgen receptor signaling in androgen-refractory prostate cancer. J Natl Cancer Inst 93: 1687-1697.
40. Heinlein CA, Chang C, (2002) Androgen receptor (AR) coregulators: an overview. Endocr Rev 23: 175-200.
41. Saitoh M, Takayanagi R, Goto K, Fukamizu A, Tomura A, et al. (2002) The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study. Mol Endocrinol 16: 694-706.
42. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, et al. (2001) SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10: 1441-1448.
43. Chi TH, Wan M, Zhao K, Taniuchi I, Chen L, et al. (2002) Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. Nature 418: 195-199.
44. Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, et al. (2008) Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity. Cancer Res 68: 4551-4558.
45. Link KA, Burd CJ, Williams E, Marshall T, Rosson G, et al. (2005) BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25: 2200-2215.
46. Ding D, Xu L, Menon M, Reddy GP, Barrack ER, (2004) Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate 58: 23-32.
47. Albertelli MA, Scheller A, Brogley M, Robins DM, (2006) Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol 20: 1248-1260.
48. Miyamoto H, Yeh S, Wilding G, Chang C, (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci U S A 95: 7379-7384.